Older women diagnosed with breast cancer could also face heart failure according to a recent report conducted by the Yale School of Medicine.

Heart failure is a relatively common complication in older women with breast cancer, but the risk is even higher in those patients treated with adjuvant trastuzumab (Herceptin©), Yale School of Medicine researchers report in the current issue of the Journal of the American College of Cardiology. Read on…